ST-1535 | Interleukin Related interleukin-related.com

Product Name :
ST-1535

Search keywords :
ST 1535

drugId :
null

Target Vo:
Adenosine A2a receptor

Target Vo Short Name :
ADORA2A

Moa_Name:
Adenosine A2a receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Alfasigma Usa Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Parkinson Disease

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Gantenerumab Technical Information
STAT5b Rabbit mAb Technical Information
CDT1 Antibody: CDT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 60 kDa, targeting to CDT1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts